New Guides: Understanding Dementia Risk, Genetics, Diagnosis in Communities of Color
Is an Alzheimer’s clinical trial right for you? What does it mean to enroll in an Alzheimer’s clinical…
Common opioid is not that effective for easing chronic pain, study finds
Tramadol, a potent synthetic opioid, has been widely used to treat moderate to severe pain, but a new…
FDA rejects Rexulti-Zoloft combo for PTSD
The FDA rejected Otsuka and Lundbeck’s Rexulti and Zoloft combination treatment for PTSD, months after raising concerns about…
Draghi had a plan to save Europe’s economy. We’ve rated it, a year in – POLITICO
Joint debt: Let’s see Draghi has been a consistent advocate for EU joint borrowing of the kind carried…
Life Bio: epigenetic rejuvenation ‘transcends organs’
Longevity biotech presents data demonstrating therapeutic impact of partial epigenetic reprogramming across multiple biological systems. Today at the…
Alzheimer’s Med Continues to Deliver Benefit at 3 Years
Data from the TRAILBLAZER-ALZ 2 long-term extension (LTE) study demonstrated that donanemab (Kisunla, Eli Lilly and Company) continues…
ADHD Meds Offer Benefits Far Beyond Core Symptom Relief
Attention-deficit/hyperactivity disorder (ADHD) medications appeared to reduce the risk of suicide, drug misuse, transport incidents, and criminal activity,…